Anirvan Ghosh - 02 Aug 2023 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact or Anirvan Ghosh
Issuer symbol
UBX
Transactions as of
02 Aug 2023
Transactions value $
-$1,708
Form type
4
Filing time
03 Aug 2023, 16:13:01 UTC
Previous filing
01 Aug 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$1.71K -581 -0.69% $2.94 83.5K 02 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.